健康元：子公司通过马来西亚药监局GMP认证

Core Viewpoint - Health元's subsidiary, Health元 Haibin Pharmaceutical Co., Ltd., has successfully passed the compliance inspection by the Malaysian National Pharmaceutical Regulatory Agency (NPRA) for its inhalation suspension (hormone) and inhalation solution production line, receiving the GMP certificate on November 20, 2025 [1] Group 1 - The certification indicates that Health元 Haibin's production and quality management systems meet the PIC/SGMP standards [1] - This achievement will facilitate the registration and market launch of the company's inhalation formulation products in Malaysia and other PIC/S member countries [1] - The certification is expected to have a positive impact on the overseas market expansion of the subsidiary's related products [1]